The White House Just Confirmed Why We Have a VIP Membership
Republicans Sound the Alarm Over Biden's Latest Partnerships With the World Health Organiz...
The Biden Admin's Failing Foreign Policy Embarrasses America Again
Biden Breaks Silence on Pro-Terrorist Student Unrest
Why the International Criminal Court's Case Against Israel Is a Farce
KJP Stutters When Questioned About Who Is Funding the Pro-Hamas College Protests
Hundreds of UCLA Students Convert to Islam, Pray to Allah
A ‘Trans’ Athlete Will Compete in a Women’s Water Polo Championship, Again.
Pro-Hamas Protests Create Headache for Vulnerable Dem Incumbent Sen. Jon Tester
How Excited Should We Really Get Over This Michigan Poll?
NYPD Patrol Chief Has Best Response to City Official Upset Over Crackdown on...
A Fifth Body From the Baltimore Bridge Collapse Was Recovered
Senate Republicans Make Their Thoughts About Biden's Plan to Accept Palestinian Refugees K...
Another Country Severs All Diplomatic Ties With Israel
House Passes Bill Codifying Definition of Antisemitism
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement